GMED today
$71.96-$0.34 (-0.47%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourSymmetric Triangle
15 minStrong Bearish
5 minLeaning Bearish
Daily trend turns down below $77.60
Key levels
Resistance$77.60
Resistance$72.54
Latest news & SEC filings
NewsGlobus Medical insider sells company stock
SEC FilingGlobus Medical Inc filed an insider trading report (Form 4)
AnalystTruist Securities keeps Buy rating on Globus Medical, cuts price target to $90
All GMED news →About Globus Medical
Globus Medical develops and sells medical devices for musculoskeletal conditions, including spinal implants, robotics, navigation, and regenerative biologics. Its products include cervical and lumbar fusion systems, artificial discs, and the ExcelsiusGPS robotic platform. The company serves surgeons and hospitals, primarily in the United States, and also markets internationally.
Based on the company's 10-K filed Feb 24, 2026.
NYSE · Healthcare
GLOBUS MEDICAL INC (GMED)
What Is the Price Target for GMED?
SEPT Low Target
$80.00
SEPT Mid Target
$99.00
SEPT High Target
$117.00
Analyst Consensus
$99.00
Is GMED a Buy or Sell Right Now?
Thesis
- •Revenue growing 16.6% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GMED.
Start Free Trial →Is GMED Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$112.72
52
Moat Score
NARROW
8/9
Piotroski Score
10.6
Altman Z-Score
What Is Smart Money Doing with GMED?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
BUYING
2 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| TOBIN JAMES R | director | Buy | 15,000 | $976K | Nov 10, 2026 |
| TOBIN JAMES R | director | Buy | 21,458 | $1.1M | Nov 10, 2026 |
| TOBIN JAMES R | director | Buy | 5,208 | $227K | Nov 10, 2026 |
| TOBIN JAMES R | director | Sale | 37,662 | $2.8M | Nov 10, 2026 |
| TOBIN JAMES R | director | Sale | 4,004 | $303K | Nov 10, 2026 |
| RHOADS ANN D | director | Sale | 5,000 | $425K | Nov 4, 2026 |
| TOBIN JAMES R | director | Buy | 15,000 | $806K | Sep 15, 2026 |
| TOBIN JAMES R | director | Sale | 30,000 | $2.2M | Sep 15, 2026 |
| Davidar David D | director | Buy | 25,000 | $657K | Jun 5, 2026 |
| Davidar David D | director | Sale | 25,000 | $2.0M | Jun 5, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GMED Growth Story
Revenue YoY
16.6%
3yr Revenue CAGR
42.2%
EPS Growth YoY
422.67%
FCF Growth YoY
45.3%
Revenue Trend
STRONG
Dark Pool Trades for GMED
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GMED, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:47:06 | $71.97 | 1,300 | $$94K | MIDPOINT |
| 18:47:06 | $71.97 | 1,300 | $$94K | MIDPOINT |
| 18:45:44 | $71.97 | 1,300 | $$94K | MIDPOINT |
| 18:45:44 | $71.97 | 1,300 | $$94K | BUY |
| 18:39:59 | $71.97 | 1,300 | $$94K | MIDPOINT |
5 dark pool trades shown · $$468K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for GLOBUS MEDICAL INC (GMED) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GMED — frequently asked questions
What is GMED stock price today?
GLOBUS MEDICAL INC (GMED) is at $71.96, down 0.47% (-$0.34) at the Nov 13, 2026 close.
Why is GMED stock moving today?
Latest GMED news — Nov 13, 2026: Globus Medical insider sells company stock · Nov 12, 2026: Globus Medical Inc filed an insider trading report (Form 4)
What is the GMED price target?
The average analyst price target for GMED is $99.00, ranging from $80 to $117, based on 7 analysts. Latest: RBC Capital maintains on Oct 1, 2026.
What do analysts rate GMED?
Analyst ratings for GMED: 0 Buy, 10 Hold, 0 Sell — consensus Hold.
Did GMED beat earnings?
GMED last reported on Aug 6, 2026: EPS $1.34 vs $1.10 expected — a beat of 21.8%.
What is GMED's P/E ratio?
GMED trades at a P/E of 22.4 vs a Healthcare average of 18.5.
Does GMED pay a dividend?
GMED does not currently pay a dividend.
What are GMED support and resistance levels?
Resistance: $72.54, $77.60, $83.43.
What are insiders doing with GMED?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on GMED?
Nov 13, 2026: Globus Medical insider sells company stock · Nov 12, 2026: Globus Medical Inc filed an insider trading report (Form 4) · Nov 9, 2026: Truist Securities keeps Buy rating on Globus Medical, cuts price target to $90